Brazilian Journal of Implantology and Health Sciences · May 15, 2026
Effect of polypharmacy on quality of life and life expectancy in older adults
By Macedo AB, Giesta FL, das Neves MV et al.
Population aging has brought about important changes in the global epidemiological profile, with an increase in the prevalence of chronic diseases and a consequent expansion of continuous medication use among older adults. In this context, polypharmacy, generally defined as the concomitant use of five or more drugs, has become a frequent condition in geriatric clinical practice and a challenge for health systems. This study aimed to analyze the recent literature on the influence of polypharmacy on quality of life and life expectancy in the older population. This is a narrative literature review conducted using publications indexed in the PubMed, SciELO, and Google Scholar databases between 2020 and 2025. The results demonstrate that polypharmacy is associated with increased adverse reactions, drug interactions, recurrent hospitalizations, functional impairment, frailty, and mortality. A negative impact on quality of life resulting from reduced autonomy, cognitive worsening, and poor treatment adherence was also observed. It is concluded that polypharmacy constitutes an important risk factor for unfavorable clinical outcomes in older adults, requiring continuous monitoring and strategies to rationalize treatment to promote healthy aging.
doi.org/10.36557/2674-8169.2026v8n5p950-959Open accessPopulations